Three times a week, skin
Timing and details
Loading…
Also known as: GLOW 70 · GLOW peptide · GLOW Stack · GLOW Blend · GHK-Cu/BPC/TB · GLOW Pen
Updated 22 sources
How it is thought to work. Each part brings its own claimed role: GHK-Cu for collagen and skin remodeling, BPC-157 for local repair, TB-500 for cell migration. None of this has been tested as a blend. For pure skin goals, several guides say GHK-Cu alone, often topical, is the closer fit.
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Doses shown are what sources report, labelled by origin. Not medical advice.
Full GLOW dosage guideEvery titration step in syringe units, missed doses and how to mix.Recipe
| Water | Strength | 2.33 mgtotal blend, units | 3.5 mgtotal blend, units | 7 mgtotal blend, units |
|---|---|---|---|---|
| 70 mg vial | ||||
| 2 mLCompetitor guide | 35 mg/mL | 6.70.067 mL | 100.1 mL | 200.2 mL |
| 3 mLCompetitor guide | 23.333 mg/mL | 100.1 mL | 150.15 mL | 300.3 mL |
| Component | Per vial | 2.33 mg total blend | 3.5 mg total blend | 7 mg total blend |
|---|---|---|---|---|
| GHK-Cu | 50 mg | 1.664 mg | 2.5 mg | 5 mg |
| BPC-157 | 10 mg | 332.9 mcg | 500 mcg | 1 mg |
| TB-500 | 10 mg | 332.9 mcg | 500 mcg | 1 mg |
| Water | Strength | 2.33 mgtotal blend, units | 3.5 mgtotal blend, units | 7 mgtotal blend, units |
|---|---|---|---|---|
| 42 mg vial | ||||
| 2 mLCompetitor guide | 21 mg/mL | 11.10.111 mL | 16.70.167 mL | 33.30.333 mL |
| Component | Per vial | 2.33 mg total blend | 3.5 mg total blend | 7 mg total blend |
|---|---|---|---|---|
| GHK-Cu | 27 mg | 1.498 mg | 2.25 mg | 4.5 mg |
| BPC-157 | 5 mg | 277.4 mcg | 416.7 mcg | 833.3 mcg |
| TB-500 | 10 mg | 554.8 mcg | 833.3 mcg | 1.667 mg |
| Water | Strength | 2.33 mgtotal blend, units | 3.5 mgtotal blend, units | 7 mgtotal blend, units |
|---|---|---|---|---|
| 42 mg vial | ||||
| 2 mLCompetitor guide | 21 mg/mL | 11.10.111 mL | 16.70.167 mL | 33.30.333 mL |
| Component | Per vial | 2.33 mg total blend | 3.5 mg total blend | 7 mg total blend |
|---|---|---|---|---|
| GHK-Cu | 30 mg | 1.664 mg | 2.5 mg | 5 mg |
| BPC-157 | 6 mg | 332.9 mcg | 500 mcg | 1 mg |
| TB-500 | 6 mg | 332.9 mcg | 500 mcg | 1 mg |
Doses shown are what sources report, labelled by origin. Not medical advice.
Calculate with this peptideYour vial, your water, your dose: GLOW in syringe units, with the math shown.Community-reportedFrom 900 Reddit posts and comments, last mined Oct 23, 2026r/Peptides, r/Peptidesource, r/Biohackers, r/PeptideDiscussion
Goal not stated59 mentions
| Reported | Mentions |
|---|---|
| 2 mg | 13 |
| 1 mg | 7 |
| 0.5 mg | 3 |
| 2.3 mg | 3 |
| 2.8 mg | 2 |
Skin and hair5 mentions
| Reported | Mentions |
|---|---|
| 1 mg | 2 |
Left out: 25 mentions given in syringe units, which mean different doses in different mixes; 2 mentions far outside every sourced protocol, most likely vial sizes or typos.
| Reported | Mentions |
|---|---|
| Once a day | 35 |
| 5 days on, 2 off | 7 |
| Twice a day | 4 |
| Every other day | 2 |
Injection site pain11 mentions
Insomnia8 mentions
Most common fix: lower the dose (2)
Bruising7 mentions
Pain7 mentions
Welts7 mentions
Stinging7 mentions
Most common fix: dilute with more bacteriostatic water (3)
Doses shown are what sources report, labelled by origin. Not medical advice.
From community reports and dosing guides. Not measured rates.
Brief; blamed on the GHK-Cu
How people manage it
Fades within an hour
Common
Week 1, or the first 1 to 2 days
First 1 to 2 weeks
Slight
Cancer historyCondition
Listed as a reason to avoid by guides.
Wilson's diseaseCondition
A copper disorder, and GHK-Cu is most of the vial.
Liver diseaseCondition
Listed as a reason to avoid by guides.
PregnancyCondition
Listed as a reason to avoid by guides.
Tested sportCondition
BPC-157 and TB-500 are prohibited by WADA at all times.
KLOWSubstance
The two overlap almost entirely; guides say run one or the other.
Freezer at -20 C or below. Fridge at 2 to 8 C is fine short term.
Fridge at 2 to 8 C, dark, upright, never frozen. Most guides say 28 days. One splits it by part: BPC-157 and GHK-Cu up to 30 days, TB-500 only 1 to 2 weeks. No blend stability study exists. Mixed with plain water, about 24 hours.
Mixed with: Bacteriostatic water
Mixing. 70 mg is the total, not each. 42 mg vials are listed as 27/5/10 mg by two sources and 30/6/6 mg by another; no source gives the 35 mg recipe. Light blue or blue-green is normal; discard if cloudy, green or brown.
Guides call GLOW compatible with GLP-1 drugs such as semaglutide and retatrutide.
Described as compatible with CJC-1295 and ipamorelin; clinics also pair it with MOTS-c.
Adding KPV turns GLOW into KLOW. Do not run both, since they overlap.
No study of the blend in humans or animals. GHK-Cu has small human topical trials, BPC-157 limited human pilots, and the TB-500 fragment animal data only. Forum reports, such as faster recovery after hernia surgery, are single anecdotes.
An approval withdrawn, or removed from FDA's compounding lists.
Not FDA approved. The 2026-04-15 notice removed BPC-157, the TB-500 fragment and injectable GHK-Cu from 503A Category 2 because nominations were withdrawn. In July 2026 an advisory committee recommended BPC-157 and TB-500 for the 503A list (reported 8 to 6), against staff advice. GHK-Cu review is due by end of February 2027.
WADA 2026 names BPC-157 under S0 and thymosin beta-4 and its derivatives, such as TB-500, under S2.3, prohibited at all times. That makes GLOW prohibited for tested athletes. No final FDA rule was found.
WADA: Prohibited
50 mg GHK-Cu, 10 mg BPC-157 and 10 mg TB-500 in a 70 mg vial. The 70 mg is the total, not each. One site says GLOW is usually just GHK-Cu and BPC-157; every other source includes TB-500.
3 mL is the norm for a 70 mg vial. One guide uses 2 mL.
10 units at 3 mL, once daily, is the consensus.
Both are published: 10 units daily at 3 mL, or 10 units Monday, Wednesday and Friday at 2 mL for 8 to 12 weeks.
One guide does, at 3 mL: under 55 kg 7.5 units, 55 to 85 kg 10 units, 85 to 110 kg 12 units, over 110 kg 14 units. Nobody else does.
Guides give 4 weeks then 2 to 4 off, 4 to 6 on and 2 to 4 off, or 8 to 12 on and 4 to 8 off. One says the GHK-Cu part governs cycling at 30 to 60 days on and equal time off. A seller suggests 6 to 12 weeks for skin and 4 to 6 for recovery.
A seller describes 5 to 10 units, sometimes split across small sites, judged over 4 to 8 weeks.
No. The fixed ratio cannot reach 2 to 5 mg of TB-500 twice weekly. People who want that run separate vials: BPC-157 250 to 500 mcg a day, TB-500 2 to 5 mg twice weekly, GHK-Cu 1 to 2 mg a day.
About 30 days at 10 units daily.
About 264 mcg of elemental copper at 10 units and 395 mcg at 15 units (3 mL dilution).
The copper peptide. More water, a room-temperature vial and a slow push help.
Guides say no, and point to topical GHK-Cu instead. IM injection is also called a mistake; it is a subQ product.
Guides list a cancer history, Wilson's disease, liver disease, pregnancy and tested sport.
Not approved. Its parts are under 503A review, and WADA prohibits it.
Answers come from this site's pages only, with a link to each source.
22 sources, each checked by date. Record updated Oct 23, 2026. Numbers are restated in our own words and labelled by where they came from.